TVTX logo

Travere Therapeutics (TVTX) EV/EBITDA

EV/EBITDA:

-9.78+0.05(+0.51%)
July 1, 2025

Summary

  • As of today (July 2, 2025), TVTX EV/EBITDA is -9.78, with a rise of +0.05 (+0.51%) during the most recent trading session on July 1, 2025.
  • Over the past year, TVTX EV/EBITDA has dropped by -6.78 (-226.00%).
  • TVTX EV/EBITDA is now -105.39% below its all-time high of 181.49.

Performance

TVTX EV/EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

OtherTVTXvaluation metrics

EV/EBITDA Formula

EV/EBITDA =  
Enterprise Value
TTM EBITDA

TVTX EV/EBITDA Trends

PeriodPeriodEV/EBITDAEV/EBITDAEnterprise valueEnterprise valuePricePrice
todaytoday+0.5%-0.5%-0.6%
1 m1 month+1.6%-1.6%-2.1%
3 m3 months---15.7%
6 m6 months-39.3%-11.9%-15.6%
ytdytd-39.3%-11.9%-15.6%
1 y1 year-226.0%+65.6%+77.7%
5 y5 years+32.7%+60.3%-28.9%

TVTX EV/EBITDA Highs & Lows

PeriodPeriodHighHighCurrent vs highvs highLowLowCurrent vs lowvs low
1 m1-month-9.45-3.5%-10.21+4.2%
3 m3-month-9.45-3.5%-13.38+26.9%
6 m6-month-7.01-39.5%-13.38+26.9%
1 y1-year-2.99-227.1%-13.38+26.9%
3 y3-year-2.05-377.1%-13.38+26.9%
5 y5-year-2.05-377.1%-26.18+62.6%
alltimeall time181.49-105.4%-5339+99.8%

TVTX EV/EBITDA History

DateValue
2025
-9.78(+39.3%)
2024
-7.02(+123.6%)
2023
-3.14(-60.4%)
2022
-7.93(-48.2%)
2021
-15.32(+40.4%)
2020
-10.91(+55.0%)
2019
-7.04(-50.8%)
DateValue
2018
-14.31(-29.9%)
2017
-20.40(+3.9%)
2016
-19.64(-450.7%)
2015
5.60(-130.3%)
2014
-18.48(+141.3%)
2013
-7.66(-99.7%)
2012
-2308.72

FAQ

  • What is Travere Therapeutics EV/EBITDA?
  • What is the all time high EV/EBITDA for Travere Therapeutics?
  • What is TVTX EV/EBITDA year-to-date change?
  • What is Travere Therapeutics EV/EBITDA year-on-year change?

What is Travere Therapeutics EV/EBITDA?

The current EV/EBITDA of TVTX is -9.78

What is the all time high EV/EBITDA for Travere Therapeutics?

Travere Therapeutics all-time high EV/EBITDA is 181.49

What is TVTX EV/EBITDA year-to-date change?

Travere Therapeutics EV/EBITDA has changed by -2.76 (-39.32%) since the beginning of the year

What is Travere Therapeutics EV/EBITDA year-on-year change?

Over the past year, TVTX EV/EBITDA has changed by -6.78 (-226.00%)
On this page